Tinox

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tinox

Quick Facts

Property Description
Active ingredient Tibolone
Form Tablet
Pharmacological class Synthetic Steroid Hormone / Hormone Replacement Therapy (HRT) Agent
Common use Management of oestrogen deficiency symptoms in postmenopausal women
Origin Synthetic (manufactured)

What Type of Medicine is Tinox?

Tinox is a prescription-only medication that contains the active ingredient known as Tibolone. This substance belongs to the high-level pharmacological class of Synthetic Steroid Hormones and is specifically used as an agent within Hormone Replacement Therapy (HRT). Tibolone is a single-component product distinguished by its role as a prodrug, meaning the substance itself is initially inactive and requires metabolism by the body to become effective. It is supplied as a tablet intended for oral administration.


Is Tibolone a Natural or Synthetic Hormone?

Tibolone is a substance entirely synthetic in origin, chemically manufactured rather than derived from a naturally occurring source. This synthetic steroid is formulated into a solid oral preparation, with its high-level composition being the active compound plus standard pharmaceutical excipients necessary for the tablet form. Tibolone's metabolites exert specific activity on three key hormone receptor types—estrogen, progestogen, and androgen. The unique triple hormone regulation achieved is clinically recognized for providing a distinct therapeutic approach for patients.


General Purpose and Benefit of Tinox

The general purpose of Tinox is to manage and relieve discomforting symptoms associated with oestrogen deficiency in postmenopausal women. This is achieved because the drug acts as a Selective Tissue Estrogenic Activity Regulator (STEAR). This mechanism allows the drug to selectively influence hormone receptors, helping to mitigate menopausal discomfort and assisting in the prevention of bone loss through its specialized tissue selectivity. By targeting support in this way, the medicine provides relief from common effects of menopausal hormone decline.

Regulatory References

  1. MedlinePlus: Menopause Hormone Therapy
  2. Tibolone (EU Register)

What side effects are possible with Tinox?

Documented High-Level Serious Safety Risks

The safety profile for Tinox (Tibolone) is structured around several serious adverse reactions documented in regulatory warnings. Use of this medication is associated with an increased risk of stroke, which epidemiological data indicates is primarily observed in women over 60 years of age. An elevated risk of venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, is also documented, with the risk noted to be highest during the first year of treatment initiation.

Regarding malignancies, the official labeling confirms an association with an increased risk of endometrial cancer in women with an intact uterus, with this risk increasing with the duration of use. An increased risk of breast cancer has also been noted in some studies. Immediate discontinuation is mandated upon the development of signs such as jaundice or sudden, significant increases in blood pressure.


Common and System-Related Adverse Reactions

Adverse reactions classified as Common (affecting 1/100 to < 1/10 users) largely involve the reproductive system and general physical changes, as detailed in regulatory product information. Reactions documented under Reproductive System and Breast Disorders commonly include:

  • Vaginal bleeding (unscheduled bleeding) or spotting, which may occur during the initial months of treatment.
  • Endometrial hyperplasia (thickening of the womb lining).
  • Breast tenderness or pain.

Common adverse reactions documented in other System-Organ Classes include weight gain (Metabolism and Nutrition Disorders) and hirsutism or increased hair growth (Skin and Subcutaneous Tissue Disorders).


Safety-Related Restrictions and Constraints

The medicine is subject to several explicit contraindications. It is restricted for use in patients with a known history of arterial or venous thromboembolic disease and is contraindicated in individuals with active liver dysfunction or disease where liver function tests have not returned to normal. Use is also forbidden in those with known or suspected estrogen-dependent malignant tumours.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Tinox (Tibolone) overdose focuses on documenting acute events and mandating immediate actions. Regulatory information suggests that taking more than the prescribed dose is unlikely to cause serious harm.

Documented Manifestations and Actions

The clinical signs of acute over-ingestion are officially documented as mild and non-severe. These manifestations include nausea, vomiting, and localized vaginal bleeding or spotting. No specific severe, systemic, or life-threatening outcomes are listed in the official overdose sections.

Classification Official Regulatory Statement
Severity Acute overdose is defined as non-severe; unlikely to cause serious harm.
Antidote No specific antidote is known for acute overdose.

Management of overdose is strictly limited to symptomatic and supportive treatment. Regulators explicitly mandate that urgent medical attention must be sought immediately following a suspected overdose, even if the individual exhibits no obvious signs of discomfort. This ensures professional clinical assessment and required monitoring.

Therapeutic Uses of Tinox

Tinox may be part of symptomatic management for symptoms that interfere with daily functioning and is considered relevant for easing the overall symptom load during phases of increased distress. Therapeutic approaches include its use for conditions involving symptomatic and functional distress. It supports patients during episodes of heightened symptoms.


Easing Sudden or Intensified Symptom Discomfort

Tinox is commonly used across conditions characterized by periods of heightened symptoms or recurrent manifestations, and is considered relevant in conditions involving symptoms related to physical discomfort or systemic imbalance. It is applied across domains where additional symptomatic support is needed in situations involving certain distressing symptoms.

“Tinox is relevant for easing discomfort and may help patients cope more steadily when symptoms lead to temporary functional strain.”

Quick Fact: Supports Management of Noticeable Physiological Strain


Supporting Stability and Functional Management

Tinox may be relevant when groups of symptoms appear suddenly or fluctuate, and it may assist with short-term symptomatic assistance. It supports the patient during difficult episodes and assists with maintaining functional stability when symptoms may escalate temporarily and become more disruptive, contributing to easing the overall symptom load.

Eligibility and Restrictions for Use

Tinox (tibolone) is a prescription medicine intended exclusively for postmenopausal women and is subject to strict eligibility rules documented in official regulatory labeling. Use is permitted only for women who are at least 12 months past their last natural menstrual period. Women who experience menopause due to surgery may begin treatment immediately.


Contraindications: Who Must Not Use Tinox

The medicine is contraindicated and must not be used by patients who have or have a history of:

  • Breast cancer or any other oestrogen-dependent malignant tumours.
  • Active or past arterial or venous thromboembolic disease (e.g., heart attack, stroke, DVT, pulmonary embolism) or known thrombophilic disorders.
  • Acute liver disease or any liver disease where liver function tests have not returned to normal.
  • Undiagnosed vaginal bleeding or untreated endometrial hyperplasia.
  • Pregnancy or lactation.

Age and Condition Restrictions

Regulatory documents state there is no relevant use for Tinox in the pediatric population (le 18 years of age). For women over 60 years of age, the decision to prescribe must specifically include consideration of the risk of stroke. Close medical supervision is required for patients with pre-existing conditions such as diabetes mellitus, hypertension, endometriosis, or Systemic Lupus Erythematosus (SLE).

What should I know about interactions with other medicines?

Tinox Interactions with other medicines and products

Official documentation on the interaction profile of Tinox (Tibolone) focuses on pharmacokinetic changes and pharmacodynamic effects with co-administered substances. The profile establishes several high-level interaction classifications.

Category Officially Documented Constraint
Contraindicated Combination Co-administration with a separate progestogen is strictly prohibited due to the product's intrinsic hormonal activity.
Pharmacokinetic Vulnerability Enzyme Inducers, specifically strong CYP3A4 inducers like Rifampicin and certain anticonvulsants (e.g., Phenytoin), are documented to reduce the systemic exposure of Tinox and its active metabolites.
Exposure Alteration Tinox may increase the activity of Anticoagulants such as Warfarin and Acenocoumarol, a pharmacodynamic interaction that requires close and routine monitoring of coagulation status (INR).

This regulatory profile notes that strong enzyme inducers and the herbal product St. John's wort are classified as clinically significant interactions that may result in a loss of the medicine's therapeutic effect. Furthermore, pharmacodynamic antagonism is documented with agents like Aromatase Inhibitors and Antidiabetic Agents where co-administration may diminish the efficacy of the other drug. This interaction structure is derived from formal regulatory-aligned safety reviews, establishing specific constraints on combination use.

Mechanism of Action

How Tinox Works


The mechanism of action is initiated by Tibolone, a prodrug that undergoes rapid metabolism into three primary active compounds. These metabolites function as agonists (activators) on three crucial biological targets: the Estrogen Receptor (ER), the Progesterone Receptor (PR), and the Androgen Receptor (AR).

Physiological outcomes are achieved by a Selective Tissue Estrogenic Activity Regulator (STEAR) mechanism, which is regulated by local enzymes. In bone and the central nervous system (CNS), the mechanism promotes receptor activation to regulate pathway activity. Conversely, in the uterine lining and breast tissue, metabolites modulate enzymes like Steroid Sulfatase to promote local estrogen deactivation, influencing cellular division.

The receptor activation in bone tissue suppresses the activity of osteoclasts—the cells responsible for bone breakdown—leading to a net effect of reduced osteoclast activity. Activation of the ER and AR within the CNS stabilizes the body’s thermoregulatory set-point, leading to modulation of activity within those pathways.

Dosage and Administration Information

How to Use Tinox: Administration Guidelines

This section outlines the standardized administration protocol for Tinox (Tibolone), detailing the route, dosage, and scheduling requirements.


Administration Protocol

Parameter Instruction
Route of Administration The medicine is administered orally in tablet form.
Standard Daily Dosing The established dose is one 2.5 mg tablet once daily.
Frequency and Timing The tablet must be taken once daily as part of a continuous, uninterrupted regimen, preferably at the same time each day.
Ingestion Manner The tablet should be swallowed whole with water and may be taken with or without food.
Duration Principle Therapy should be used for the shortest duration necessary to manage symptoms.

Procedural Rules for Initiation and Missed Doses

Administration of Tinox adheres to procedural requirements related to the timing of menopause and handling of deviations from the schedule.

Treatment must generally commence at least 12 months after the last natural menstrual bleed for women undergoing natural menopause. If switching from a sequential hormone replacement therapy (HRT) regimen, treatment should start on the day following the completion of the prior treatment.

If a dose is missed, it should be taken immediately if the scheduled time is less than 12 hours overdue. If more than 12 hours have passed since the dose was due, the missed tablet must be skipped, and the daily schedule resumed at the usual time; taking a double dose is not permitted.

Note on Concomitant Use: The regimen specifies that a separate progestogen should not be concurrently added when using this medicine.

Recent Clinical Evidence

Research evidence / Overview of Studies for Tinox

This section provides a factual overview of the clinical research conducted on the active ingredient Tibolone, as reported in authoritative scientific and regulatory documents. It summarizes the types of studies performed, the outcomes measured, and the limitations noted by researchers, without offering clinical interpretation, advice, or claims of effectiveness.


Evidence for Use in Managing Oestrogen Deficiency Symptoms

Research exploring how symptoms change over time has primarily involved short-term Randomized Controlled Trials (RCTs). These studies were designed to measure changes in common discomforts like the frequency and severity of vasomotor symptoms and symptoms related to urogenital atrophy. These findings were applied in studies examining patient-reported experiences and used in research exploring short-term symptom changes, typically lasting three to six months.

Research so far indicates that studies reported how symptoms evolved in the observed populations during the study period. However, some trials comparing the substance to conventional hormone therapies described patterns suggesting varied symptom response in the short term. The characterization of symptom patterns over longer durations is limited, as observation periods for these measures were often short-term.


Evidence for Use in Evaluating Postmenopausal Bone Density

Research has explored Tibolone in studies evaluating bone mineral density and fracture incidence in women after menopause through larger, more extended Intervention Trials and Systematic Reviews. Research monitored outcomes related to the measurement of two main physiological markers: changes in Bone Mineral Density (BMD), measured over approximately two years, and the actual documentation of fracture incidence, tracked over periods of nearly three years in some large trials.

Studies monitored patterns related to BMD measurements. Research described observed patterns in fracture incidence in older women with established osteoporosis from one major trial. Results related to BMD changes were used as a measure in research to explore short-term findings related to bone density, contributing to the broader evidence landscape. Data for fracture reduction for younger women remain insufficient. The long-term changes in bone density and fracture incidence beyond the period monitored in the major intervention trials are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Tinox (FAQ)


Q: Is Tinox appropriate for use by elderly patients?

Official documents indicate that no specific dose adjustment is needed for older patients. However, for women over the age of 60, the decision to use the medication must include careful consideration of the increased risk of stroke. This specific risk assessment is a key regulatory constraint for this age group.


Q: Does Tinox cause weight gain or loss?

Weight gain is listed as a common undesirable effect in official clinical trial data. Information from regulatory sources does not commonly report weight loss as a frequent effect of the medicine.


Q: Can Tinox be taken if I am also taking vitamins or herbal supplements?

The regulatory information specifically identifies the herbal product St. John’s wort as a substance that may reduce the effectiveness of this medicine and should not be used. Official guidance emphasizes the importance of a patient's healthcare provider being aware of all supplements and vitamins taken, as interactions may exist beyond those specifically listed.


Q: How does Tinox interact with common blood pressure medications?

Regulatory guidance notes that Tinox may cause or worsen fluid retention, which can affect blood pressure and requires monitoring. Official documents also describe that close supervision is needed for patients who have pre-existing hypertension (high blood pressure) or other cardiovascular risk factors.


Q: Have there been long-term studies published about using Tinox for many years?

Studies examining long-term outcomes, such as changes in bone mineral density, typically track results for approximately two to three years. Official information indicates that the effects beyond the period monitored in the major intervention trials are not fully established. For this reason, the duration of treatment is monitored and periodically reassessed by a healthcare professional.


Q: Why do some people report feeling no change after starting Tinox?

Regulatory documents do not address individual user reports, but clinical trials have reported patterns suggesting a varied symptom response when compared to conventional hormone therapies. This indicates that individual results and the time needed to observe changes may differ among users.


Q: Can Tinox be crushed or split if a patient has trouble swallowing?

Official administration guidelines state that the tablet should be swallowed whole with water. Information in patient leaflets often notes that crushing or chewing the tablets should be avoided, as regulatory testing indicates this may prevent them from working as intended.


Q: Are there any specific foods or drinks to avoid while on Tinox?

According to regulatory administration instructions, the tablet may be taken either with or without food. Official interaction profiles do not contraindicate specific foods, but they do classify the herbal product St. John’s wort as a significant interaction to avoid.


Q: Why are people with certain heart conditions generally advised against using Tinox?

The medicine is strictly contraindicated (forbidden) for patients with a history of arterial or venous thromboembolic disease. This contraindication includes serious conditions such as stroke, heart attack, and deep vein thrombosis, due to the drug's established risk profile.


Q: Is the condition that Tinox treats considered curable with this medicine?

Regulatory documents state that the medicine is indicated for the treatment and management of symptoms related to estrogen deficiency and for the prevention of bone loss. It is not described in official documentation as a medication that provides a cure for the underlying condition.


Q: How is Tinox removed or cleared from the body?

Official pharmacokinetic data describes that the medicine is processed by the body into active metabolites. The predominant route of elimination is via the faeces, with a smaller amount being excreted through the urine.


Q: Is there a maximum recommended period for continuously taking Tinox?

Official guidance states that therapy should be used for the shortest duration necessary to manage symptoms. While usage for 2 to 5 years is common, the overall treatment duration should be regularly reviewed by a medical professional based on risk-benefit assessment.


Q: Do I need special monitoring (like blood tests) while on Tinox?

Yes, special monitoring is often described as necessary in certain situations. Patients using anticoagulants require routine monitoring of blood-clotting status, and pre-treatment liver function tests must be normal for all users. Close supervision is also required for patients with pre-existing conditions like diabetes or hypertension.


Q: Does Tinox interact with oral contraceptives or hormone replacement therapy?

Tinox is itself a form of hormone replacement therapy and official rules prohibit adding a separate progestogen. Furthermore, Tinox is not a contraceptive, and women under 50 should rely on a non-hormonal contraceptive method.


Q: What percentage of people experience the most common side effects?

According to official product information, side effects that are classified as 'common' are those that affect between 1 in 100 and 1 in 10 users. This descriptive range is used in regulatory documents to classify event frequency.


Q: Does Tinox lose potency if exposed to heat or light?

Regulatory storage instructions state that the medicine must be stored in the original package and protected from both light and moisture. While specific temperature storage is not always required, official advice is often to keep the product below 25 C to maintain product quality.


Q: What is the earliest point I might start noticing the effects of Tinox?

Studies and official product information indicate that the onset of relief from menopausal symptoms is generally observed within the first few weeks of starting treatment. The initial assessment of the medicine's effectiveness is typically conducted at the three-month stage.


Q: How long does the effect of one dose of Tinox typically last in the body?

Official pharmacokinetic data indicates that the half-life of the active metabolites is approximately seven hours. The medicine is prescribed on a once-daily regimen to ensure consistent drug levels are maintained in the body throughout the day.


Q: Is it normal to feel a bit tired when starting Tinox?

Undesirable effects that were commonly listed in clinical trials do not include fatigue or tiredness. Any unusual or unexpected symptoms experienced should be brought to the attention of a healthcare provider for proper evaluation.


Q: Can taking Tinox affect the results of common lab tests?

Official regulatory-aligned documents indicate that this medication may interfere with the results of certain lab tests, such as those for blood clotting and thyroid function, potentially leading to false results. It is noted in product information that lab personnel and all prescribing doctors should be made aware that this medication is being used.


Q: Can people with mild kidney issues use Tinox?

The regulatory profile indicates that the elimination of the active ingredient is generally not dependent on renal function. However, official guidance emphasizes the necessity of a medical professional evaluating these risks, as use is associated with the potential for fluid retention and blood pressure effects.


Q: Are there different strengths of Tinox available?

The standard marketed dose is the 2.5 mg tablet, which is taken once daily. Some regulatory documents reference clinical research on a lower 1.25 mg dose, but the standard prescribed product is typically the 2.5 mg strength.


Q: Can Tinox affect my ability to drive or operate machinery?

The official product information states that the medicine is not known to have any effects on alertness or concentration. It is not expected to impair a user's ability to drive or operate heavy machinery.


Q: What is the typical time frame for the drug to reach steady state in the body?

Pharmacokinetic principles described in regulatory text suggest that the drug is expected to reach a consistent level (known as the steady state) in the body within two days, based on the active metabolites' half-life.


Q: What does 'Black Box Warning' mean in relation to Tinox?

The medicine does not have a 'Black Box Warning.' This specific type of warning is a regulatory requirement only for the U.S. Food and Drug Administration (FDA), and this product has not been approved for use in the U.S. market.


Q: Are allergic reactions to Tinox common?

Severe allergic reactions are generally rare. Official documents state that the medicine is contraindicated (must not be used) in patients who have previously had an allergic reaction to the active ingredient, Tibolone, or any of the inactive ingredients.


Q: Can I use Tinox if I have a history of depression or anxiety?

Official regulatory-aligned documents list depression as a possible side effect and note that other mood changes, such as nervousness, may occur. Official documentation notes that patients with a history of mood disorders may require close medical supervision.


Q: What happens if a person stops taking Tinox suddenly?

Stopping suddenly is not known to cause specific withdrawal symptoms. Regulatory-aligned documents note that gradual dose reduction may be implemented by a healthcare professional to help prevent menopausal symptoms from returning. It is recommended that any cessation or change in regimen be discussed with a medical professional.

How should Tinox be stored and disposed of?

How to Store and Dispose of Tinox

Official regulatory guidelines strictly define the storage and disposal of Tinox (Tibolone) tablets to maintain product stability and ensure safety.


Storage Requirements

Tinox must be stored below 25°C (controlled room temperature). The product should be kept in its original package to protect from light and moisture, and the container must remain tightly closed.


Child Safety and Stability

For safety, the medicine must be kept out of the sight and reach of children at all times. The approved shelf-life is typically 30 months (or 3 years) when stored correctly; do not use the tablets after the expiry date.


Disposal Instructions

Do not throw away unused or expired Tinox via wastewater or household waste. Disposal must be conducted in accordance with local requirements. Consult your pharmacist about authorized drug take-back programs to safely discard the medication.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Tinox found in:

A-Z Index: